Cargando…
Distinct immunological activation profiles of dSLIM® and ProMune® depend on their different structural context
INTRODUCTION: DNA‐based TLR9 agonists are potent activators of the immune system. ProMune® and dSLIM® belong to different families of TLR9 agonists and both have been established as cancer immunotherapeutics in clinical proof‐of‐concept studies. Unfortunately, ProMune® failed in pivotal oncological...
Autores principales: | Kapp, Kerstin, Schneider, Jacqueline, Schneider, Lisa, Gollinge, Nadine, Jänsch, Stefanie, Schroff, Matthias, Wittig, Burghardt, Kleuss, Christiane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5134728/ https://www.ncbi.nlm.nih.gov/pubmed/27980779 http://dx.doi.org/10.1002/iid3.126 |
Ejemplares similares
-
Genuine Immunomodulation With dSLIM
por: Kapp, Kerstin, et al.
Publicado: (2014) -
Design and characterization of the tumor vaccine MGN1601, allogeneic fourfold gene-modified vaccine cells combined with a TLR-9 agonist
por: Volz, Barbara, et al.
Publicado: (2016) -
Cationic Lipid-Formulated DNA Vaccine against Hepatitis B Virus: Immunogenicity of MIDGE-Th1 Vectors Encoding Small and Large Surface Antigen in Comparison to a Licensed Protein Vaccine
por: Endmann, Anne, et al.
Publicado: (2014) -
Motor Unit Number Estimation (MUNE) Free of Electrical Stimulation or M Wave Recording: Feasibility and Challenges
por: Chen, Maoqi, et al.
Publicado: (2022) -
Fully automated F-wave corridor extraction and analysis algorithm for F-wave analyses and MUNE studies
por: Artuğ, N. Tuğrul
Publicado: (2023)